Efficacy of Zn Biofortified Wheat in Improving Zn Status in Indian School Children With Low Zn Status
Launched by SWISS FEDERAL INSTITUTE OF TECHNOLOGY · Sep 15, 2014
Trial Information
Current as of June 20, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • generally healthy
- Exclusion Criteria:
- • unhealthy
About Swiss Federal Institute Of Technology
The Swiss Federal Institute of Technology (ETH Zurich) is a prestigious research university located in Switzerland, renowned for its cutting-edge scientific research and innovation. With a strong emphasis on interdisciplinary collaboration, ETH Zurich leverages its expertise in engineering, natural sciences, and technology to advance healthcare solutions through clinical trials. The institute is committed to improving patient outcomes and advancing medical knowledge by conducting rigorous, ethically-sound research that adheres to the highest standards of scientific integrity. Its distinguished faculty and state-of-the-art facilities position ETH Zurich as a leader in clinical research, fostering partnerships that bridge academia, industry, and healthcare institutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bangalore, Karnataka, India
Patients applied
Trial Officials
Michael B Zimmermann, Prof Dr med
Principal Investigator
ETHZ
Anura V Kurpad, Prof MD PhD
Principal Investigator
St John's Research Institute, Bangalore
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials